2014 Canadian Melanoma Conference
Mark Your Calendars!
February 20 to 23, 2014
Rimrock Resort Hotel, Banff, Alberta
2014 Conference Date Announcement
The 2014 Canadian Melanoma Conference will take place at the Rimrock
Resort Hotel Februray 20 to 23, 2014. Mark your calendars!
Overview
The Canadian Melanoma Conference is Canada's flagship meeting on the research
and treatment of melanoma. It brings together Medical Oncologists, Surgeons,
Dermatologists, Radiotherapists, Pathologists, Molecular Biologists, and
Immunologists to review the latest evidence and explore new therapies.
This event is an Accredited Group Learning Activity (Section 1) as defined
by the Maintenance of Certification program of the Royal College of Physicians
and Surgeons of Canada, and approved by the Division of Continuous Professional
Learning, University of Alberta
2013 Learning Objectives
- Communicate state-of-the-art knowledge in biology, pathogenesis,
and melanoma pathology
- Review the biological basis of bRAF inhibition and the clinical implications
in the management of melanoma
- Present pre-clinical and clinical research regarding Braf inhibition
in melanoma
- Provide an update on the use of anti-CTLA4 therapy, including the
evaluation of response and the management of immune-related toxicities
- Review the specific challenges of acral melamonas
- Share novel research strategies and initiatives being conducted across
Canada
- Identify new targets and targeted agents in the treatment of melanoma
such as PD-1
- Identify key industry partners who would prioritize the development
of products and programs in melanoma management in Canada
- Continue to build the network of basic and clinical investigators
in order to promote translational and clinical research across Canada
- Discuss short- and long-term research strategies
Program Planning Committee
Chair: Michael Smylie, Medical Oncologist, Department of Medical Oncology, Cross Cancer Institute; Professor, University of Alberta
Joel Claveau, Melanoma and Pigmented Lesions Clinic, Hôpital Hôtel-Dieu de Québec
Scott Ernst, Head, Division of Medical Oncology, London Regional Cancer Program
David Hogg, Professor of Medicine, Departments of Medicine and Medical Biophysics, University of Toronto
Greg McKinnon, Professor of Surgery and Oncology, University of Calgary and Tom Baker Cancer Centre
Teresa Petrella, Medical Oncologist, Sunnybrook Odette Cancer Centre
Thomas Salopek, Director of Dermatology, Associate Professor, University of Alberta
Alan Spatz, Professor of Pathology and Oncology, Department of Pathology, McGill University
|